 |
2016-05-16 02:12:00 A ●●●●●● of ●●●●●●pes essay ●●●●●● ●●●●●●ore This news ●●●●●●e ●●●●●●es ●●●●●●d-●●●●●●g ●●●●●●ents that ●●●●●●e risks and ●●●●●●●●●●●●s ●●●●●●ng to ●●●●●● ●●●●●● and the ●●●●●● ●●●●●●mance of R●●●●●●on, and ●●●●●● ●●●●●● or ●●●●●●s may ●●●●●● ●●●●●●ally from these ●●●●●●d-●●●●●●g ●●●●●●ents. Words such as "●●●●●●pate," "●●●●●●," "●●●●●●," "plan," "●●●●●●e," "seek," "●●●●●●te," ●●●●●●ions of such words, and ●●●●●●r ●●●●●●sions are ●●●●●●ed to ●●●●●●fy such ●●●●●●d-●●●●●●g ●●●●●●ents, ●●●●●●gh not all ●●●●●●d-●●●●●●g ●●●●●●ents ●●●●●●n these ●●●●●●fying words. These ●●●●●●ents ●●●●●●n, and these risks and ●●●●●●●●●●●●s ●●●●●●e, among ●●●●●●, the ●●●●●●, ●●●●●●, and ●●●●●●le ●●●●●●s and ●●●●●●eutic ●●●●●●●●●●●● of R●●●●●●on's ●●●●●●ts, ●●●●●●t ●●●●●●ates, and ●●●●●●ch and ●●●●●●al ●●●●●●ms now ●●●●●●ay or ●●●●●●d, ●●●●●●ing ●●●●●●t ●●●●●●tion ●●●●●●umab; ●●●●●●seen ●●●●●● ●●●●●● ●●●●●●ing from the ●●●●●●●●●●●●on of ●●●●●●ts and ●●●●●●t ●●●●●●ates in ●●●●●●ts, ●●●●●●ing ●●●●●●s ●●●●●●●●●●●●s or side ●●●●●●s in ●●●●●●tion with the use of R●●●●●●on's ●●●●●●t ●●●●●●ates in ●●●●●●al ●●●●●●; the ●●●●●●hood and ●●●●●● of ●●●●●●le ●●●●●●tory ●●●●●●al and ●●●●●●cial ●●●●●● of R●●●●●●on's late-stage ●●●●●●t ●●●●●●ates; ●●●●●●●●●●●●ns by ●●●●●●tory and ●●●●●●●●●●●●ve ●●●●●●●●●●●● ●●●●●●ities which may delay or ●●●●●●ct R●●●●●●on's ●●●●●●y to ●●●●●●ue to ●●●●●●p or ●●●●●●●●●●●●e R●●●●●●on's ●●●●●●ts and ●●●●●●t ●●●●●●ates; ●●●●●●ing drugs and ●●●●●●t ●●●●●●ates that may be ●●●●●●or to R●●●●●●on's ●●●●●●ts and ●●●●●●t ●●●●●●ates; ●●●●●●ainty of ●●●●●● ●●●●●●ance and ●●●●●●cial ●●●●●●s of R●●●●●●on's ●●●●●●ts and ●●●●●●t ●●●●●●ates; the ●●●●●●y of R●●●●●●on to ●●●●●●cture and ●●●●●● ●●●●●● ●●●●●● for ●●●●●●le ●●●●●●ts and ●●●●●●t ●●●●●●ates; ●●●●●●ge and ●●●●●●●●●●●●t ●●●●●●●●●●●●ns by third-party ●●●●●●, ●●●●●●ing M●●●●●●e and M●●●●●●d; ●●●●●●●●●●●●d ●●●●●●es; the costs of ●●●●●●ping, ●●●●●●ing, and ●●●●●●g ●●●●●●ts; the ●●●●●●y of R●●●●●●on to meet any of its sales or other ●●●●●●ial ●●●●●●tions or ●●●●●●ce and ●●●●●●s to the ●●●●●●tions ●●●●●●ying those ●●●●●●tions or ●●●●●●ce; the ●●●●●●ial for any ●●●●●●e or ●●●●●●●●●●●●n ●●●●●●ent, ●●●●●●ing R●●●●●●on's ●●●●●●ents with Sanofi and Bayer HealthCare, to be ●●●●●●led or ●●●●●●ated ●●●●●●t any ●●●●●●r ●●●●●●t ●●●●●●s; and risks ●●●●●●ated with third party ●●●●●●●●●●●● ●●●●●●ty and ●●●●●●g or ●●●●●● ●●●●●●tion ●●●●●●ng ●●●●●●o. A more ●●●●●●te ●●●●●●ption of these and other ●●●●●●al risks can be found in R●●●●●●on's ●●●●●●s with the United States S●●●●●●ies and E●●●●●●e C●●●●●●ion, ●●●●●●ing its Form 10-K for the year ended D●●●●●●r 31, 2012 and its Form 10-Q for the ●●●●●●r ended June 30, 2013. The ●●●●●● is ●●●●●●ned not to rely on any ●●●●●●d-●●●●●●g ●●●●●●ents made by R●●●●●●on. R●●●●●●on does not ●●●●●●ake any ●●●●●●tion to ●●●●●● ●●●●●●ly any ●●●●●●d-●●●●●●g ●●●●●●ent, ●●●●●●ing ●●●●●●t ●●●●●●tion any ●●●●●●ial ●●●●●●tion or ●●●●●●ce, ●●●●●●r as a ●●●●●● of new ●●●●●●ation, ●●●●●● ●●●●●●, or ●●●●●●ise. |